MedTrace Logo

A Study for Treatment of Partial Seizures in Children

NCT00102713 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-05-21

No results posted yet for this study

Summary

The purpose of the study is to assess the safety profile of the investigational medication, Depakote Sprinkle Capsules, in the treatment of partial seizures in children ages 3-10.

Conditions

  • Partial Seizures

Interventions

DRUG

Divalproex Sodium (Depakote Sprinkle Capsules)

Sponsors & Collaborators

Principal Investigators

  • Global Medical Information 800-633-9110 · Abbott

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00102713 on ClinicalTrials.gov